These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6312533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Remote (2-3 years) results in patients with pulmonary tuberculosis treated in operational conditions in combination with sinerdol-EH].
    Păunescu E, Mihăilescu P, Fonea M, Ciocan A, Serban G, Eliescu A, Serban S, Grigorescu C, Tiţei I, Popescu M.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(2):137-44. PubMed ID: 2825331
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
    Utkin VV.
    Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
    [No Abstract] [Full Text] [Related]

  • 4. [A new antitubercular agent: rifampicin].
    Favez G.
    Schweiz Rundsch Med Prax; 1970 Feb 24; 59(8):296-7. PubMed ID: 4996719
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Design and study of new agents having antitubercular activity: the original compound perchlosone as a potent agent of etiotropic therapy for tuberculosis].
    Vinogradova TI, Aleksandrova AE, Antonenkova EV, Elokhina VN, Nakhmanovich AS.
    Probl Tuberk; 1999 Feb 24; (3):45-7. PubMed ID: 10420769
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F.
    Int J Tuberc Lung Dis; 1999 Jun 24; 3(6):466-70. PubMed ID: 10383057
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB, Koriakin VA, Khalbaeva IV, Elistratova NA, Ziia AV.
    Probl Tuberk; 1993 Jun 24; (5):21-3. PubMed ID: 8295879
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Determination of drug resistance of Mycobacterium tuberculosis by methods of proportions and absolute concentrations].
    Golyshevskaia VI, Sevast'ianova EV, Voronina GA.
    Probl Tuberk; 2001 Jun 24; (3):51-3. PubMed ID: 11508236
    [Abstract] [Full Text] [Related]

  • 18. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo].
    Kochanova NK, Miakotina EN, Bellendir EN, Boiarkina SK, Iudelevich VI.
    Probl Tuberk; 1983 Jun 24; (6):65-8. PubMed ID: 6410375
    [No Abstract] [Full Text] [Related]

  • 19. [Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice].
    Pershin GN, Zykova TN, Kutchak SN.
    Probl Tuberk; 1977 Jan 24; (1):64-9. PubMed ID: 834763
    [No Abstract] [Full Text] [Related]

  • 20. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C, Lecocguic Y, Touaty E, Bussi S, Pariente R.
    Rev Fr Mal Respir; 1982 Jan 24; 10(6):391-9. PubMed ID: 6819611
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.